Get a Mounjaro® (tirzepatide) prescription online for type 2 diabetes

Yes, while Mounjaro is FDA-approved to treat type 2 diabetes, clinical trials show that patients who take Mounjaro often experience significant weight loss.

It slows digestion and helps you feel full for longer, so it can help support weight management alongside exercise and a reduced-calorie diet.

Mounjaro helps with diabetes by mimicking two hormones, GLP-1 and GIP, which help to control glucose levels in the body. This helps regulate blood sugar levels and reduce body weight in patients with type 2 diabetes.

It's important to note that Mounjaro is not a cure for type 2 diabetes. It helps patients manage their blood sugar levels by reducing blood glucose, but it will not reverse the condition.

Adults typically start with 2.5 mg injected under the skin once a week. After at least four weeks, your provider may increase the dose to 5 mg. Your provider may recommend further increases based on your blood sugar levels and how well you tolerate the medication.

Your provider can explain how to administer Mounjaro and where to inject it. Rotate injection sites with each dose, and don't change or stop your medication without consulting your provider.

Mounjaro pens should be stored in refrigerated conditions between 36 and 46 degrees Fahrenheit. Do not freeze Mounjaro, and do not use it if it's frozen.

If needed, the single-dose pen can be stored unrefrigerated at temperatures below 86 degrees Fahrenheit for up to 21 days. Avoid exposing the medication to excess heat or moisture.

No, Mounjaro is currently available only by prescription. This means a licensed healthcare provider must authorize its use.

If you are looking for a prescription, doctors on Sesame can write a prescription–or refill an existing one–during a virtual or in-person visit. Book an appointment with a provider on Sesame today to discuss whether or not Mounjaro is right for you.

Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer. This conclusion is based on studies where laboratory animals given semaglutide, liraglutide, tirzepatide and other GLP-1 medications developed tumors. However, it is not yet confirmed if these medications pose the same risk to humans. You can find additional information about the risks of FDA-approved medications that contain semaglutide here.

It’s important to inform your doctor if you or any family member has ever had MTC or MEN. If this is the case, your doctor will likely advise against taking GLP-1 medications.

If you are prescribed a GLP-1 medication and exhibit any of the following symptoms, you should contact your provider immediately:

• A lump or swelling in the neck
  
• Hoarseness
  
• Difficulty swallowing
  
• Shortness of breath
  
• Severe abdominal pain

Before taking GLP-1 medications, you should also discuss the following with your provider:

Allergies: Inform your doctor and pharmacist of any allergies you have to semaglutide (including under brand names Ozempic, Rybelsus, Wegovy) or similar medications such as tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide (Bydureon BCise, Byetta), liraglutide (Saxenda, Victoza, or in Xultophy) and lixisenatide (Adlyxin, or in Soliqua).

Personal and family medical history: Be sure to disclose if you have a history of medical conditions like pancreatitis, diabetic retinopathy, gallbladder disease, kidney disease, or thyroid cancer. Inform your doctor about recent episodes of diarrhea, nausea, vomiting or any inability to consume liquids, which could lead to dehydration.

Current medications and supplements: Provide a comprehensive list of all medicines and supplements you are currently taking, including prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products. This is crucial as GLP-1 medications can alter how your body absorbs oral medications.

Pregnancy and breastfeeding: Inform your doctor if you are pregnant, breastfeeding, or planning to become pregnant soon.

Surgical procedures: In the event of surgery, including dental procedures, inform the medical or dental professional that you are on GLP-1 medication.

It's essential to thoroughly discuss these risks with your healthcare provider and consider your personal and family medical history when deciding whether to use these medications. Your doctor can provide guidance on the best course of action based on your specific health situation.

You can find additional information about the risks of FDA-approved Mounjaro (tirzepatide) here.